Pharma News
-
Novartis continues to innovate in CML
Pharma | News | 0 Comment | 14 Jun, 2019
Long-term follow-up data from the ongoing, pivotal open-label ENESTfreedom and ENESTop trials showed sustained treatment-free remission (TFR) after stopping frontline and second-line Tasign...Read more
-
Pharma | News | 0 Comment | 14 Jun, 2019
Dr. Reddy’s Laboratories Limited has announced that it has entered into a definitive asset purchase agreement with Upsher-Smith Laboratories pursuant to which Dr. Redd...Read more
-
Sun Pharma’s ILUMYA improves joint and skin symptoms of Psoriatic Arthritis
Pharma | News | 0 Comment | 14 Jun, 2019
Sun Pharmaceutical Industries Ltd. recently announced interim results from a Phase 2 study of interleukin-23 (IL-23) inhibitor ILUMYA™ (tildrakizumab-asmn) in patients with activ...Read more
-
Amcor completes acquisition of Bemis
Pharma | News | 0 Comment | 12 Jun, 2019
Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home- and personal-care, and other products. Amcor has announced the...Read more
-
Dulaglutide reduces cardiovascular disease in Type-2 diabetic people
Pharma | News | 0 Comment | 10 Jun, 2019
The Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) trial has found dulaglutide, an injectable, glucagon-like peptide-1 (GLP-1) receptor agonist, dem...Read more
-
Calliditas Therapeutics to commercialize autoimmune drug in China, Singapore
Pharma | News | 0 Comment | 11 Jun, 2019
Sweden based Calliditas Therapeutics AB (“Calliditas”) and US based Everest Medicines II Limited (“Everest Medicines”) announced that they have entered into a licens...Read more
-
PTC gets FDA nod for the expansion of the EMFLAZA® labeling
Pharma | News | 0 Comment | 10 Jun, 2019
PTC Therapeutics is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits ...Read more
-
First patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia
Pharma | News | 0 Comment | 07 Jun, 2019
Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, announced on 4 June 2019, that the first patient has been dosed with its lead candidate, le...Read more
-
FSD Pharma adds two more prominent Cannabis researchers to Scientific Advisory Board
Pharma | News | 0 Comment | 07 Jun, 2019
FSD Pharma Inc. has announced the addition of two distinguished cannabis researchers to the company’s Scientific Advisory Board. “It is with great pride tha...Read more
-
Starpharma signs second oncology agreement with AstraZeneca
Pharma | News | 0 Comment | 10 Jun, 2019
Australia based Starpharma has announced a Development and Option Agreement with AstraZeneca to progress the development of a Dendrimer Enhanced Product (DEP®) version of an undisclosed...Read more
-
BioMarin receives approval for rare syndrome treatment in China
Pharma | News | 0 Comment | 07 Jun, 2019
US based BioMarin Pharmaceutical Inc. has announced that Vimizim® (elosulfase alfa) has been approved by the National Medical Products Administration (NMPA) for the treatment of patient...Read more
-
Pharma | News | 0 Comment | 06 Jun, 2019
Innovent Biologics, Inc., a world-class biopharmaceutical company, presented the research data on the treatment of relapsed or refractory extranodal NK/T cell lymphoma (ORIENT-4) by sintili...Read more
-
Takeda to discontinue trial in AL Amyloidosis
Pharma | News | 0 Comment | 06 Jun, 2019
Takeda Pharmaceutical Company Limited has announced that the Phase 3 TOURMALINE-AL1 clinical trial in patients with relapsed or refractory systemic light-chain (AL) amyloidosis did not...Read more
-
Syneos Health Consulting releases 11th annual survey of Biopharmaceutical dealmakers
Pharma | News | 0 Comment | 06 Jun, 2019
The 11th annual Dealmakers’ Intentions Study from Syneos Health Consulting, an industry-leading biopharmaceutical management consulting firm, indicates that there will be an accelerat...Read more
-
Pharma | News | 0 Comment | 06 Jun, 2019
Eli Lilly and Company recently announced that the U.S. Food and Drug Administration has approved Emgality (galcanezumab-gnlm) injection (300 mg) for the treatment o...Read more
-
Pharma | News | 0 Comment | 06 Jun, 2019
RemeGen, Ltd. announced positive promising results for a Phase II clinical trial of RC48 on 4 June 2019, in Yantai, China. Results, presented at the 2019 American Society of Clinical O...Read more
-
Otsuka Chemical acquires Cefixime business of Astellas Pharma
Pharma | News | 0 Comment | 10 Jun, 2019
Otsuka Chemical Co., Ltd has announced its acquisition on cefixime business from Astellas Pharma, Inc. on 5 June 2019, in Tokyo, Japan. Through this agreement, Otsuka Chemical acquir...Read more
-
PeptiDream announces strategic partnership with drug-delivery expert PharmaIN
Pharma | News | 0 Comment | 06 Jun, 2019
PeptiDream Inc., a public Kanagawa-based biopharmaceutical company, on 5 June 2019, announced a strategic partnership with Seattle-based PharmaIN Corporation for the purpose of investi...Read more
